Common origin but individual outcomes: time for new guidelines in personalized healthcare

Personalized Medicine
Olga Golubnitschaja, Vincenzo Costigliola

Abstract

Clinical observations clearly demonstrate that similar endogenous and exogenous risk factors cause individual reactions and pathologic characteristics; therefore, the same therapeutic approaches applied within one cohort of patients lead to individual outcomes. How could we optimize approaches used in the current healthcare systems? Individualized treatment algorithms and paradigm change from a late interventional approach to predictive diagnosis, followed by the targeted prevention of a disease before pathology manifests, presents an innovative concept for advanced healthcare that is cost effective. Predictive perinatal/postnatal diagnosis and the preselection of a particular healthy but disease-predisposed individual, followed by targeted preventive measures, represent the primary task in the overall action of personalized healthcare. Those highly effective measures can lead to a reduced prevalence of severe pathologies and better long-term outcomes for patients treated according to individual parameters and therapeutic algorithms. Furthermore, an increased portion of socially active members remaining vibrant with excellent physical and mental health can therefore, be expected in the elderly. Improving the quality of life of ...Continue Reading

References

Aug 1, 1994·AACN Clinical Issues in Critical Care Nursing·D G Thompson
Aug 29, 1998·Molecular and Cellular Endocrinology·P D GluckmanA Gunn
Mar 24, 1999·Pediatric Research·K GustafsonJ Isgaard
May 20, 1999·Journal of the American College of Cardiology·J F BeltrameA Maseri
Jun 1, 1999·Life Sciences·O LabudovaB Lubec
Sep 26, 2000·Life Sciences·R SeidlG Lubec
Mar 29, 2001·Biology of the Neonate·W AkhterM Delivoria-Papadopoulos
Apr 5, 2001·Progress in Retinal and Eye Research·J FlammerT Resink
Nov 9, 2001·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·J Flammer
Nov 20, 2001·Brain Injury : [BI]·C MañeruJ Guardia
Aug 12, 2003·The Journal of Experimental Biology·Dietmar Kültz
Feb 24, 2004·Archives of Disease in Childhood. Fetal and Neonatal Edition·W B BørkeO D Saugstad
Nov 19, 2004·Nature·Joan Massagué
Dec 21, 2004·Acta Ophthalmologica Scandinavica·Barbara TeuchnerJosef Flammer
Feb 16, 2005·Annual Review of Physiology·Dietmar Kültz
Feb 16, 2005·Annual Review of Physiology·Evangelia CharmandariGeorge Chrousos
Jan 19, 2007·International Journal of Cancer. Journal International Du Cancer·Lonneke V van de Poll-FranseHarm R Haak
Dec 6, 2007·Survey of Ophthalmology·Olga Golubnitschaja, Josef Flammer
Mar 11, 2008·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·S NouriH Seboui
Nov 10, 2009·Expert Review of Molecular Diagnostics·Anil S Modak
Dec 26, 2009·Current Diabetes Reviews·Olga Golubnitschaja
Mar 1, 2010·The EPMA Journal·Babitha GeorgeKristina Yeghiazaryan

❮ Previous
Next ❯

Citations

Nov 13, 2012·The EPMA Journal·Tatiana A BodrovaSergey V Suchkov
Jun 1, 2011·The EPMA Journal·Olga GolubnitschajaVincenzo Costigliola
May 1, 2011·Personalized Medicine·Kristina YeghiazaryanOlga Golubnitschaja
Nov 5, 2020·The EPMA Journal·Adriana Torres CrignaOlga Golubnitschaja

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.